Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, Raymond Liu, Tom Wai‐Hin Chung, Man-Yee Chu, Yuk-Yung Ng, Jenny Lo, Jacky Man Chun Chan, Anthony Raymond Tam, Hoi‐Ping Shum, Veronica Chan, Alan Wu, Kit-Man Sin, Wai-Shing Leung, Wai-Lam Law, David Christopher Lung, Wai Ching Sin, Pauline Yeung, Cyril Chik‐Yan Yip, Ruiqi Zhang, Agnes Yim-Fong Fung, Erica Yuen-Wing Yan, Kit-Hang Leung, Jonathan Daniel Ip, Allen Wing‐Ho Chu, Wan-Mui Chan, Anthony Ng, Rodney Lee, Kitty S. C. Fung, Alwin Yeung, Tak-Chiu Wu, Johnny Wai-Man Chan, Wing-Wah Yan, Wai-Ming Chan, Jasper Fuk‐Woo Chan, Albert Kwok-Wai Lie, Owen Tak-Yin Tsang, Vincent Chi‐Chung Cheng, Tak-Lun Que, Chak-Sing Lau, Kwok‐Hung Chan, Kelvin Kai‐Wang To, Kwok-Yung Yuen